OakChart

Embecta Corp

EMBCHealthcare·Medical Instruments & Supplies·USA·Small·NASD·Nov 11 • 3:59 PM ET

6.53+0.10 (1.56%)
2026-11-12 00:19 CET
Market cap
364.32 USD m
Revenue, TTM
1,018.70 USD m
Net income, TTM
87.50 USD m
Free cash flow, TTM
164.60 USD m
EPS diluted, TTM
1.48
P/E
4.40
Compare

Price

EMBC against its 20, 50 and 200-day averages
2050200beat
2.505.007.5010.005.7M11.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26EMBCclose 6.5320-day 6.4450-day 5.94200-day 6.226.5352w low

56.2% under the 52-week high of 14.91 on 12 Nov 2025. 52-week low 2.77 on 20 May 2026. Last 15 sessions, 19.4% high to low

Volume 0.64× normal · the line is the 50-bar volume average

Profile

EMBC
52-week range, 31% of the way up
2.7714.91

Embecta Corp. engages in the provision of medical devices used in the treatment of diabetes. Its products include pen needles, syringes, and safety devices complemented by a digital application. The company was founded in 1924 and is headquartered in Parsippany, NJ.

IndexRUT
Employees1850
IPOMar 22, 2022
Beta0.80
ATR, 14d0.33
Rel volume0.64
Short float11.19%
Insider own8.24%
Inst own87.12%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap369.99M
Enterprise Value1.65B
Income87.50M
Sales1.02B
Book/sh-10.81
Cash/sh3.85
Dividend Est.0.25 (3.86%)
Dividend TTM0.32 (4.90%)
Dividend Ex-DateAug 27, 2026
Dividend Gr. 3/5Y58.74% -
Payout37.05%
Employees1850
IPOMar 22, 2022

Ratios

P/E4.40
Forward P/E3.70
PEG-
P/S0.36
P/B-
P/C1.70
P/FCF2.25
EV/EBITDA5.11
EV/Sales1.62
Quick Ratio1.17
Current Ratio1.68
Debt/Eq-
LT Debt/Eq-
Option/ShortYes / Yes

Earnings

EPS (ttm)1.48
EPS next Y1.76
EPS next Q0.29
EPS this Y-37.76%
EPS next Y-3.96%
EPS next 5Y-12.88%
EPS past 3/5Y-25.52% -
Sales past 3/5Y-1.47% -0.10%
EPS Y/Y TTM4.11%
Sales Y/Y TTM-7.60%
EPS Q/Q-53.64%
Sales Q/Q-8.05%
EarningsAug 07 BMO
EPS/Sales Surpr.110.68% 6.75%

Ownership

Insider Own8.24%
Insider Trans2.38%
Inst Own87.12%
Inst Trans-18.99%
ROA7.22%
ROE-
ROIC11.83%
Gross Margin59.63%
Oper. Margin26.38%
Profit Margin8.59%
SMA201.32%
SMA509.99%
SMA2004.97%
Trades-

Technical

Shs Outstand56.66M
Shs Float51.99M
Short Float11.19%
Short Ratio5.18
Short Interest5.82M
52W High14.91 -56.20%
52W Low2.77 135.74%
Volatility7.23% 5.04%
ATR (14)0.33
RSI (14)56.91
Beta0.80
Rel Volume0.64
Avg Volume1.12M
Volume721,042

Performance

Perf Week0.15%
Perf Month5.32%
Perf Quarter27.79%
Perf Half Y109.29%
Perf YTD-45.03%
Perf Year-54.08%
Perf 3Y-55.91%
Perf 5Y-
Perf 10Y-
Recom3.20
Target Price4.00
Prev Close6.43
Price6.53
Change %1.56%

Analyst ratings

latest 9 of 9
DateActionAnalystRating changeTargetImplied
May 06, 2026DowngradeBBTIG ResearchBuy → Neutral
Apr 10, 2025InitiatedMMizuhoNeutral$15+129.7%
Dec 02, 2024UpgradeMMorgan StanleyUnderweight → Equal-Weight$13 → $20+206.3%
Nov 27, 2024UpgradeBBTIG ResearchNeutral → Buy$26+298.2%
Oct 20, 2023InitiatedWWolfe ResearchPeer Perform
Jan 06, 2023DowngradeMMorgan StanleyEqual-Weight → Underweight$28+328.8%
Sep 08, 2022InitiatedBBTIG ResearchNeutral
Aug 01, 2022InitiatedMMorgan StanleyEqual-Weight$33+405.4%
Jun 21, 2022InitiatedBBofA SecuritiesUnderperform$25+282.8%

Peers

Mkt cap
TickerCompanyMkt cap
BDXBecton Dickinson & Co58.43B
MMEDMiniMed Group Inc5.13B
RVPRetractable Technologies Inc16.60M
KRMDKORU Medical Systems Inc179.60M
TNDMTandem Diabetes Care Inc1.31B
ICUIICU Medical Inc4.46B
BBNXBeta Bionics Inc968.27M
PODDInsulet Corp10.41B
MNKDMannkind Corp1.35B
SENSSenseonics Holdings Inc570.81M

Insider trading

6 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Morris Milton MayoDirectorSep 04 '26Sale5.886,29336,97153,828Sep 08 05:13 PM
Morris Milton MayoDirectorSep 04 '26Proposed Sale5.866,29336,891Sep 04 03:07 PM
Kurdikar DevdattPresident and CEOAug 12 '26Buy4.7030,000140,937804,919Aug 13 10:50 AM
Elguicze JacobSVP and CFOAug 12 '26Buy4.6720,00093,360309,139Aug 13 10:48 AM
Mann Jeffrey ZPres, Pharm Svc&Prod Mgmt, CLOAug 12 '26Buy4.9920,00099,800262,915Aug 13 10:47 AM
HOMBACH ROBERT J.DirectorAug 12 '26Buy4.9745,000223,848109,587Aug 13 10:45 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWMiShares Russell 2000 Index FundAUM: 77.38B
IWNiShares Russell 2000 Value ETFAUM: 14.10B
CALFPacer US Small Cap Cash Cows ETFAUM: 3.86B
VXFVanguard Extended Market Index ETFAUM: 30.47B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
DESWisdomTree U.S. SmallCap Dividend FundAUM: 2.12B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VFVAVanguard U.S. Value Factor ETFAUM: 984.27M

News

latest 14 of 196

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-08-070.5600.2660.360271.7254.534
2026Q22026-05-050.2700.417-0.069221.8235.674
2026Q12026-02-050.7100.6710.744261.2258.074
2025Q42025-11-250.5000.4550.449263.3265.674
2025Q32025-08-081.1200.7750.778295.5278.254
2025Q22025-05-090.7000.5280.401259253.95
2025Q12025-02-060.6500.4930.000261.9257.024
2024Q42024-11-260.4500.3620.251286.1276.975
2024Q32024-08-090.7400.4640.254272.5267.445
2024Q22024-05-090.6700.4000.500287.2264.74
2024Q12024-02-090.6100.4550.349277.3264.924
2023Q42023-11-210.5900.3980.104281.9271.554
2023Q32023-08-080.6900.4600.264286.1275.073
2023Q22023-05-120.7500.4830.243277.1262.883
2023Q12023-02-140.9600.5100.615275.7262.93
2022Q42022-12-20-0.3000.597-0.302274.6261.013

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY3.8904.5403.9191,1301,117
2023FY2.9902.8001.2191,1211,112
2024FY2.4502.3861.3421,1231,115
2025FY2.9502.9251.6201,0801,082
2026FY-1.836--1,022
2027FY-1.763--1,066
2028FY-1.951--1,087
2029FY-2.960--1,090
2030FY-3.060--1,094

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-21500267.37258270.45
2026Q4S2026-10-12504267.37258270.45
2026Q4S2026-10-01504267.37258270.45
2026Q4S2026-08-07404269.71268.2270.45
2026Q4S2026-08-01400283.56277.3286.23
2026Q4S2026-07-19401283.56277.3286.23
2026Q4S2026-07-10404283.56277.3286.23
2026Q4S2026-05-18404283.56277.29286.23
2026Q4S2026-05-16303282.67277.29286
2026Q4S2026-05-13403284.88277.29291.52
2026Q4S2026-05-08403284.88277.29291.52
2026Q4S2026-05-06403284.88277.3291.52
2026Q4S2026-05-05403284.88277.29291.52
2026Q4S2026-04-21400290.86290291.52

Estimate history

EPS, annual--7.3063.9191.2191.3421.6191.4837
Period2019202020212022202320242025TTM
EPS, quarterly0.2540.25100.4010.7780.4490.744-0.0690.361
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1109108611651129.51120.81123.11080.41018.7
Period2019202020212022202320242025TTM
Sales, quarterly272.5286.1261.9259295.5264261.2221.8271.7
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.0010.00156.80557.05557.33357.70758.49656.66
Period2019202020212022202320242025MRQ
Shares, quarterly57.67657.70758.13258.32758.47358.49659.21259.32856.66
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue1,018.701,080.401,123.101,120.801,129.501,165.001,086.001,109.00
Cost of Goods Sold Incl. D&A411.20400.90394.20370.90354.60365.00323.00323.00
Gross Profit607.50679.50728.90749.90774.90800.00763.00786.00
Selling, General and Administrative Excl. Other335.20352.90443.90426.50359.80303.00276.00284.00
Research and Development15.9021.5078.8085.2065.0063.0061.0062.00
Other Operating Expense3.60-2.70110.8093.8037.005.000.000.00
Operating Income268.70329.30174.20229.60378.10492.00487.00502.00
Interest Expense96.70107.30112.30107.0046.200.000.000.00
Unusual Expense55.3087.207.408.1068.500.000.000.00
Net Income Before Taxes125.00136.3044.20105.70256.60495.00486.00500.00
Income Taxes37.5040.90-34.1035.3033.0080.0058.0068.00
Consolidated Net Income87.5095.4078.3070.40223.60415.00428.00432.00
Net Income From Continuing Operations87.5095.4078.3070.40223.60415.00428.00432.00
Net Income87.5095.4078.3070.40223.60415.00428.00432.00
EPS (Recurring)2.162.661.431.324.767.31--
EPS (Basic, Before Extraordinaries)1.491.641.361.233.927.31--
EPS (Diluted)1.481.621.341.223.927.31--
EBITDA323.30380.40216.70262.30409.80530.00525.00538.00
Non-Operating Income (Expense)8.301.50-10.30-8.80-6.803.00-1.00-2.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense21.2827.6023.4019.2015.809.499.498.76
Price To Earnings Ratio4.334.3311.6818.337.39---
Price To Sales Ratio0.190.770.730.781.45---
Gross Margin59.6362.8964.9066.9168.6168.6770.2670.87
Operating Margin26.3830.4815.5120.4933.4742.2344.8445.27
Net Margin8.598.836.976.2819.8035.6239.4138.95
Shares Outstanding56.6658.5057.7157.3357.0656.800.000.00
Market Capitalization364.32364.32813.60862.401,664.231,700.07--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue271.70221.80261.20264.00295.50259.00261.90286.10
Cost of Goods Sold Incl. D&A121.0096.6085.60108.00100.5097.5095.00114.80
Gross Profit150.70125.20175.60156.00195.00161.50166.90171.30
Selling, General and Administrative Excl. Other84.2081.6077.9091.5088.2082.9090.20116.60
Research and Development5.605.400.304.603.803.709.5019.80
Other Operating Expense2.200.700.600.100.700.10-0.2021.10
Operating Income64.3042.9097.1064.40106.1078.5076.9033.60
Interest Expense23.9022.6024.1026.1026.6026.7027.9029.00
Unusual Expense15.607.9023.907.9012.1015.6048.207.40
Net Income Before Taxes27.609.5058.9029.0072.2035.80-0.70-7.00
Income Taxes6.5013.6014.802.6026.7012.30-0.70-21.60
Consolidated Net Income21.10-4.1044.1026.4045.5023.500.0014.60
Net Income From Continuing Operations21.10-4.1044.1026.4045.5023.500.0014.60
Net Income21.10-4.1044.1026.4045.5023.500.0014.60
EPS (Recurring)0.550.021.030.540.920.590.580.34
EPS (Basic, Before Extraordinaries)0.36-0.070.750.450.780.400.000.25
EPS (Diluted)0.36-0.070.740.450.780.400.000.25
EBITDA77.5055.70110.0080.10117.9090.2088.8045.60
Non-Operating Income (Expense)2.80-2.909.80-1.404.80-0.40-1.50-4.20
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense3.605.005.107.585.006.308.004.90
Price To Earnings Ratio4.333.737.309.8610.6912.6815.2511.68
Price To Sales Ratio0.190.500.650.770.510.691.090.73
Gross Margin55.4756.4567.2359.0965.9962.3663.7359.87
Operating Margin23.6719.3437.1724.3935.9130.3129.3611.74
Net Margin7.77-1.8516.8810.0015.409.070.005.10
Shares Outstanding56.6659.3359.2158.5058.4758.3358.1357.71
Market Capitalization364.32523.50703.44825.22566.31741.211,200.40813.60

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments228.60274.20326.50330.900.000.00-
Short Term Receivables148.90248.0017.9023.40151.00120.00-
Inventories178.60171.50152.10122.80118.00102.00-
Other Current Assets75.3067.30252.60187.6023.0013.00-
Total Current Assets631.40761.00749.10664.70292.00235.00-
Net Property, Plant & Equipment277.40313.00323.20307.90455.00467.00-
Total Investments and Advances0.000.000.000.000.000.00-
Intangible Assets22.4023.7024.7024.6034.0030.00-
Deferred Tax Assets124.80------
Other Assets61.30187.60117.4089.207.006.00-
Total Assets1,117.301,285.301,214.401,086.40788.00738.00-
Short Term Debt Incl. Current Port. of LT Debt19.8018.9019.0015.101.001.00-
Accounts Payable74.2091.0053.5041.4054.0050.00-
Income Tax Payable9.8026.7033.6027.20---
Other Current Liabilities157.70237.40247.40217.30109.0086.00-
Total Current Liabilities261.50374.00353.50301.00164.00137.00-
Long Term Debt1,427.601,607.401,640.801,635.003.004.00-
Provision for Risks Charges0.000.000.000.000.000.00-
Deferred Tax Liabilities26.40---27.0025.00-
Other Liabilities52.4042.2041.8041.800.000.00-
Total Liabilities1,767.902,023.602,036.101,977.80194.00166.00-
Non-Equity Reserves0.000.000.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.000.000.00-
Common Equity-650.60-738.30-821.70-891.40594.00572.00-
Total Shareholders Equity-650.60-738.30-821.70-891.40594.00572.00-
Accumulated Minority Interest0.000.000.000.000.000.00-
Total Equity-650.60-738.30-821.70-891.40594.00572.00-
Total Liabilities & Stockholders Equity1,117.301,285.301,214.401,086.40788.00738.00-
Book Value Per Share-11.12-12.79-14.33-15.6210.46572,000.00-
Tangible Book Value Per Share-11.51-13.20-14.76-16.059.86542,000.00-
Full-Time Employees1,8502,1002,2001,9002,029--
Price to Book Ratio-0.59-1.06-1.07-1.84-2.01--
Return on Assets7.946.266.1223.8654.39--
Return on Equity----71.18--
Return on Invested Capital12.289.018.5930.0769.5174.31-
Quick Ratio1.731.581.691.801.060.97-
Current Ratio2.412.032.122.211.781.72-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income87.5095.4078.3070.40223.60415.00428.00432.00
Depreciation54.6051.1042.5032.6031.7038.0038.0036.00
Other Funds (Non Cash)25.4051.3033.2030.4091.0036.0022.0020.00
Funds from Operations185.30215.4083.40147.70319.80487.00486.00482.00
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-11.20-23.70-47.70-80.0092.40-31.0013.0023.00
Income Taxes Payable-14.80-28.1013.20-12.6010.30---
Cash from Operating Activities174.10191.7035.7067.70412.20456.00499.00505.00
Capital Expenditures-9.50-9.30-15.80-26.50-24.00-39.00-42.00-69.00
Net Assets From Acquisitions-128.400.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources10.100.000.000.000.000.000.000.00
Cash from Investing Activities-127.80-9.30-15.80-26.50-24.00-39.00-42.00-69.00
Cash Dividends Paid-27.20-35.00-34.50-34.40-8.600.000.000.00
Change in Capital Stock-8.700.000.000.000.000.000.000.00
Repurchase of Common Pref Stock-8.700.000.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-21.50-186.00-35.90-14.301,404.500.000.000.00
Change in Long Term Debt-21.50-186.00-35.90-14.301,404.500.000.000.00
Issuance of Long Term Debt180.000.000.000.001,416.700.000.000.00
Reduction of Long Term Debt-201.50-186.00-35.90-14.30-12.200.000.000.00
Net Financing Active Other Cash Flow-4.90-5.70-3.000.00-1,443.90-417.00-457.00-436.00
Other Financing Activities Uses-4.90-5.70-3.000.00-1,443.90-417.00-457.00-436.00
Cash from Financing Activities-62.30-226.70-73.40-48.70-48.00-417.00-457.00-436.00
Exchange Rate Effect0.60-1.301.203.10-9.30---
Net Change in Cash-15.40-45.60-52.30-4.40330.900.000.000.00
Free Cash Flow164.60182.4019.9041.20388.60419.00457.00439.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.00
Price to Free Cash Flow1.395.64-127.834.32---
Deferred Taxes & Investment Tax Credit-17.60-70.6014.30-26.50-2.00-2.00-6.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments218.20193.40204.40228.60233.60212.30
Short Term Receivables182.20147.10159.20148.90182.80186.80
Inventories214.20192.60181.80178.60189.90169.20
Other Current Assets90.5075.0074.8075.3075.2075.10
Total Current Assets705.10608.10620.20631.40681.50643.40
Net Property, Plant & Equipment335.00255.00268.00277.40283.00278.50
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets87.4021.9022.1022.4022.7023.10
Deferred Tax Assets---124.80--
Other Assets137.80144.30153.4061.30170.10175.20
Total Assets1,265.301,029.301,063.701,117.301,157.301,120.20
Short Term Debt Incl. Current Port. of LT Debt149.3018.6019.7019.8019.0019.20
Accounts Payable90.5079.7072.1074.2061.9058.80
Income Tax Payable6.406.206.709.807.100.00
Other Current Liabilities173.60142.80136.20157.70187.50181.30
Total Current Liabilities419.80247.30234.70261.50275.50259.30
Long Term Debt1,352.401,353.901,390.601,427.601,498.601,549.40
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities---26.40--
Other Liabilities105.8054.2051.5052.4052.8047.70
Total Liabilities1,878.001,655.401,676.801,767.901,826.901,856.40
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-612.70-626.10-613.10-650.60-669.60-736.20
Total Shareholders Equity-612.70-626.10-613.10-650.60-669.60-736.20
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-612.70-626.10-613.10-650.60-669.60-736.20
Total Liabilities & Stockholders Equity1,265.301,029.301,063.701,117.301,157.301,120.20
Book Value Per Share-10.81-10.55-10.35-11.12-11.45-12.62
Tangible Book Value Per Share-12.36-10.92-10.73-11.51-11.84-13.02
Full-Time Employees---1,850--
Price to Book Ratio-0.59-0.85-1.07-1.23-0.77-0.96
Return on Assets7.2210.4112.617.946.904.55
Return on Invested Capital2.85-0.565.673.405.492.89
Quick Ratio1.171.681.871.731.781.83
Current Ratio1.682.462.642.412.472.48

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income21.10-4.1044.1026.4045.5023.50
Depreciation13.2012.8012.9015.7011.8011.70
Other Funds (Non Cash)7.508.10-2.3012.108.509.30
Funds from Operations44.1023.2058.1059.9072.1047.80
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.307.90-40.9024.109.10-16.00
Income Taxes Payable0.90-2.70-1.80-11.209.90-0.50
Cash from Operating Activities41.8031.1017.2084.0081.2031.80
Capital Expenditures-1.10-0.50-0.60-7.30-0.40-0.10
Net Assets From Acquisitions-128.400.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.0010.100.000.000.00
Cash from Investing Activities-129.50-0.509.50-7.30-0.40-0.10
Cash Dividends Paid-0.60-8.90-8.90-8.80-8.70-8.70
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-8.700.000.000.000.000.00
Repurchase of Common Pref Stock-8.700.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net127.10-37.90-37.90-72.80-52.80-27.70
Change in Long Term Debt127.10-37.90-37.90-72.80-52.80-27.70
Issuance of Long Term Debt180.000.000.000.000.000.00
Reduction of Long Term Debt-52.90-37.90-37.90-72.80-52.80-27.70
Net Financing Active Other Cash Flow-5.405.30-4.800.00-1.10-0.90
Other Financing Activities Uses0.00-0.10-4.800.00-1.10-0.90
Cash from Financing Activities112.40-41.50-51.60-81.60-62.60-37.30
Exchange Rate Effect0.10-0.100.70-0.103.101.20
Net Change in Cash24.80-11.00-24.20-5.0021.30-4.40
Free Cash Flow40.7030.6016.6076.7080.8031.70
Price to Free Cash Flow1.393.094.135.645.82152.34

Revenue breakdown

Manufacturing Facility2024: 12.80M 2025: 19.90M
Pen Needles2024: 844.40M 2025: 784.10M
Product and Service, Other2024: 10.30M 2025: 14.00M
Safety2024: 129.40M 2025: 137.80M
Syringes2024: 126.20M 2025: 124.60M
Non-US2024: 515.90M 2025: 501.30M
United States2024: 607.20M 2025: 579.10M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3011.19%5.8M52.0M1.28M
2026-10-1511.29%5.9M52.0M1.33M
2026-09-3011.21%5.8M52.0M1.43M
2026-09-1510.67%5.5M52.0M1.79M
2026-08-3112.01%6.3M52.2M1.86M
2026-08-1410.45%5.4M52.1M2.02M
2026-07-3112.22%6.7M54.7M2.55M
2026-07-1511.02%6.0M54.7M2.49M
2026-06-3010.69%5.8M54.7M2.33M
2026-06-1512.72%7.0M54.7M1.93M
2026-05-2913.55%7.4M54.7M1.81M
2026-05-1513.05%7.1M54.7M1.60M
2026-04-3011.11%6.0M54.5M874.01K
2026-04-1510.67%5.8M54.4M859.15K
2026-03-319.71%5.3M54.4M829.99K
2026-03-1310.34%5.6M54.4M768.63K
2026-02-278.65%4.7M54.4M770.15K
2026-02-137.42%4.0M54.4M747.10K
2026-01-307.08%3.9M54.7M622.68K
2026-01-157.00%3.8M54.7M566.38K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.503.904.604.006.3441413.000.972-0.0130.001
call5.001.451.701.451.9168650.000.922-0.0110.001
call7.500.000.050.050.7648503.000.134-0.0100.002
call10.000.000.750.051.7141120.000.071-0.0130.001
call12.500.002.150.102.3558.000.000.056-0.0150.001
call15.000.000.750.092.8447.000.000.049-0.0160.001
call17.500.002.150.003.2380.000.000.044-0.0170.001
put2.500.000.750.053.78979.000.00-0.027-0.0140.001
put5.000.000.050.051.6732490.00-0.146-0.0210.002
put7.500.551.701.182.6701060.00-0.865-0.0090.002
put10.001.904.901.905.8101.000.00-0.928-0.0130.001
put12.504.407.400.006.7390.000.00-0.943-0.0150.001
put15.006.809.900.007.4320.000.00-0.951-0.0150.001
put17.509.5012.500.008.2340.000.00-0.955-0.0160.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-084Statement of changes in beneficial ownership of securities2026-09-04SEC
2026-09-04144Filing for proposed sale of securities under Rule 144.SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-114Statement of changes in beneficial ownership of securities2026-08-09SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-078-KCurrent report2026-08-07SEC
2026-08-07S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-07-318-K/A2026-05-15SEC
2026-07-08SCHEDULE 13G/ASEC
2026-06-024Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-05-27SCHEDULE 13G/ASEC
2026-05-22SDSpecialized Disclosure ReportSEC
2026-05-158-KCurrent report2026-05-15SEC
2026-05-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-058-KCurrent report2026-05-05SEC
2026-05-05SCHEDULE 13GSEC
2026-05-01SCHEDULE 13G/ASEC
2026-04-29SCHEDULE 13GSEC
2026-03-26SCHEDULE 13G/ASEC
2026-03-208-KCurrent report2026-03-19SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC
2026-02-134Statement of changes in beneficial ownership of securities2026-02-11SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090036.97K1
2026-08557.95K400
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.7.75%
YACKTMAN ASSET MANAGEMENT LP7.65%
VANGUARD CAPITAL MANAGEMENT LLC4.31%
DEERFIELD MANAGEMENT COMPANY, L.P.4.27%
Jefferies Financial Group Inc.4.16%
AMERIPRISE FINANCIAL INC3.44%
MORGAN STANLEY3.37%
GEODE CAPITAL MANAGEMENT, LLC2.76%
STATE STREET CORP2.71%
ACADIAN ASSET MANAGEMENT LLC2.35%

Funds

Fund% owned
Lord Abbett Short Duration High Yield Fund17.78%
iShares Broad USD High Yield Corporate Bond ETF16.23%
AB HIGH INCOME FUND INC11.14%
AB Short Duration High Yield ETF10.87%
iShares 0-5 Year High Yield Corporate Bond ETF7.42%
Fidelity Advisor Floating Rate High Income Fund6.64%
State Street(R) SPDR(R) Portfolio High Yield Bond ETF6.22%
AMG Yacktman Fund5.90%
Victory Floating Rate Fund5.80%
SIIT HIGH YIELD BOND FUND5.75%

OakChart. EMBC. Cached 15 minutes.